Harvard University and biotechnology company 10x Genomics Inc. reached a settlement mid-trial with rival Vizgen Inc., concluding a legal dispute over the alleged infringement of patents related to tissue sample analysis. The agreement was achieved after three days of court proceedings, shedding light on the complex nature of intellectual property rights in the rapidly evolving biotechnology sector.
For additional insight on the matter, you can explore the full report from Law360, which discusses the intricacies of the case and the broader implications for the industry.